Drugs / IL-11
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07362810 | Jan → Dec 2026 expected | disease related to hematopoietic stem cell transplant, hemopoietic proliferation | Fudan University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07362810 ↗ |